Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$4.18M Sell
44,217
-142
-0.3% -$13.5K 0.47% 64
2018
Q2
$4.11M Hold
44,359
0.46% 62
2018
Q1
$4.2M Sell
44,359
-355
-0.8% -$39K 0.47% 63
2017
Q4
$4.32M Sell
44,714
-600
-1% -$56.5K 0.47% 65
2017
Q3
$4.03M Sell
45,314
-170
-0.4% -$12.9K 0.46% 62
2017
Q2
$3.3M Sell
45,484
-10,088
-18% -$678K 0.45% 70
2017
Q1
$3.62M Hold
55,572
0.44% 67
2016
Q4
$3.48M Sell
55,572
-1,050
-2% -$64.1K 0.44% 63
2016
Q3
$3.57M Buy
56,622
+550
+1% +$35.6K 0.47% 65
2016
Q2
$3.47M Buy
56,072
+184
+0.3% +$11.2K 0.47% 66
2016
Q1
$3.19M Sell
55,888
-150
-0.3% -$8.36K 0.44% 70
2015
Q4
$3.32M Sell
56,038
-1,510
-3% -$87K 0.47% 68
2015
Q3
$3.13M Buy
57,548
+588
+1% +$38.3K 0.46% 73
2015
Q2
$3.83M Sell
56,960
-242
-0.4% -$15.8K 0.52% 55
2015
Q1
$3.35M Sell
57,202
-87
-0.2% -$5.26K 0.45% 64
2014
Q4
$3.6M Buy
57,289
+3
+0% +$189 0.49% 57
2014
Q3
$3.31M Sell
57,286
-1,199
-2% -$66.6K 0.48% 55
2014
Q2
$3.3M Sell
58,485
-298
-0.5% -$15.6K 0.47% 56
2014
Q1
$3.02M Sell
58,783
-6,165
-9% -$312K 0.52% 58
2013
Q4
$3.43M Sell
64,948
-998
-2% -$49K 0.61% 48
2013
Q3
$2.95M Buy
65,946
+5,551
+9% +$246K 0.58% 52
2013
Q2
$2.5M Buy
+60,395
New +$2.64M 0.55% 58

Other funds holding ABBV

Rand Wealth's ABBV Position: Q3 2018 in Review

Rand Wealth reduced its AbbVie (ABBV) stake by 0.32% in Q3 2018, selling an estimated $13.5K and leaving 44,217 shares worth $4.18M. The position accounts for 0.47% of the portfolio, ranked #64.

Rand Wealth first reported a position in ABBV in Q2 2013 and has held it in 22 quarters since. The position peaked at $4.32M in Q4 2017. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Rand Wealth held 44,217 shares of AbbVie worth $4.18M as of Q3 2018.
  • Rand Wealth sold 142 AbbVie shares in Q3 2018, an estimated $13.5K.
  • AbbVie made up 0.47% of Rand Wealth's portfolio in Q3 2018, its #64 holding.
  • Rand Wealth first reported a position in AbbVie in Q2 2013 and has held it in 22 quarters since.
  • Rand Wealth's AbbVie position peaked at $4.32M in Q4 2017.
  • 1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.